Article
How do breast cancers become hormone resistant?
The Journal of steroid biochemistry and molecular biology - 1 Jun 1994
Horwitz K B
Abstract excerpt
We propose that the molecular heterogeneity of estrogen receptors (ER) in breast tumor cells characterized by the presence of mutant receptor forms, generates the cellular heterogeneity evident when progesterone receptor (PR) or DNA ploidy are analyzed in cell subpopulations. Furthermore, it is likely that cellular heterogeneity leads to the lack of uniformity in response to tamoxifen that we have described. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
